Arkolith/Insider Trading/CADL/Form 4

Barone Francesca

Chief Scientific OfficerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Mar 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$282K
Net Open-Market Flow
-$282K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2025Option exercise(M)18K$1.55$28K129K
Mar 18, 2025Sell(S)32K$8.76$282K97K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2025Option exercise(M)18K—$031K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-042726) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML